Literature DB >> 19582427

Cancer stem cells in head and neck squamous cell carcinoma.

Laurie Ailles1, Mark Prince.   

Abstract

The cancer stem cell hypothesis states that within a tumor only a subset of cells, the "cancer stem cells" (CSC), are capable of initiating and propagating the disease. In various cancers such cells have been identified and prospectively isolated based on the presence of specific cell surface antigens. In head and neck squamous cell carcinomas, we have shown that the CSCs are contained within the CD44+ subset of tumor cells. This subset contains cells capable of initiating tumor growth in mice that recapitulates the original tumor heterogeneity. Furthermore, they have a primitive cellular morphology, express high levels of nuclear BMI1, and are arrayed in characteristic tumor microdomains. The methods used to purify this subset of tumorigenic cells, to characterize their gene expression profiles, and to identify their physical location within the context of the whole tumor are described here.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582427     DOI: 10.1007/978-1-59745-280-9_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

Review 1.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Anoikis mediators in oral squamous cell carcinoma.

Authors:  J Bunek; P Kamarajan; Y L Kapila
Journal:  Oral Dis       Date:  2010-11-29       Impact factor: 3.511

3.  The probable role of tumor stem cells for lymph node metastasis in supraglottic carcinoma.

Authors:  Sumei Lu; Jiajun Tian; Zhenghua Lv; Haibo Wang; Xiaohui Bai; Wenwen Liu; Jianfeng Li; Wei Xu
Journal:  Pathol Oncol Res       Date:  2010-04-21       Impact factor: 3.201

4.  Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.

Authors:  Ryan Morrison; Stephen M Schleicher; Yunguang Sun; Kenneth J Niermann; Sungjune Kim; Daniel E Spratt; Christine H Chung; Bo Lu
Journal:  J Oncol       Date:  2010-10-12       Impact factor: 4.375

Review 5.  Pancreatic cancer stem cells and EMT in drug resistance and metastasis.

Authors:  F H Sarkar; Y Li; Z Wang; D Kong
Journal:  Minerva Chir       Date:  2009-10       Impact factor: 1.000

6.  Targeting unique metabolic properties of breast tumor initiating cells.

Authors:  Weiguo Feng; Andrew Gentles; Ramesh V Nair; Min Huang; Yuan Lin; Cleo Y Lee; Shang Cai; Ferenc A Scheeren; Angera H Kuo; Maximilian Diehn
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

7.  Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.

Authors:  M Athanassiou-Papaefthymiou; O Shkeir; D Kim; V Divi; M Matossian; J H Owen; M J Czerwinski; P Papagerakis; J McHugh; C R Bradford; T E Carey; G T Wolf; M E Prince; S Papagerakis
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jul-Sep       Impact factor: 3.219

8.  Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.

Authors:  Shiyi Yu; Xiuxiu Cai; Chenxi Wu; Lele Wu; Yuzhi Wang; Yan Liu; Zhenghong Yu; Sheng Qin; Fei Ma; Jean Paul Thiery; Liming Chen
Journal:  Oncotarget       Date:  2015-02-20

Review 9.  Links between cancer stem cells and epithelial-mesenchymal transition.

Authors:  Sha-Sha Wang; Jian Jiang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Onco Targets Ther       Date:  2015-10-16       Impact factor: 4.147

10.  Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.

Authors:  Kariem Sharaf; Axel Lechner; Stefan P Haider; Robert Wiebringhaus; Christoph Walz; Gisela Kranz; Martin Canis; Frank Haubner; Olivier Gires; Philipp Baumeister
Journal:  Curr Oncol       Date:  2021-07-19       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.